Mithril Capital Management leads $15 mln round for MagForce USA

MagForce USA, a subsidiary of MagForce AG, a cancer-focused medical device firm, has received $15 million in funding. Mithril Capital Management led the round. MagForce AG will retain a majority ownership stake in MagForce USA.

11 August 2014•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail